BTI
EDIT icon

Blue Trust Inc’s Editas Medicine EDIT Stock Holding History

Blue Trust Inc’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,600
Closed -$3.95K – 2513
2026
Q1 		$3.95K Hold
1,600
– – ﹤0.01% 2031
2025
Q4 		$3.28K Buy
+1,600
New +$4.62K ﹤0.01% 2062
2024
Q4 		– Sell
-200
Closed -$934 – 2592
2024
Q3 		$934 Hold
200
– – ﹤0.01% 2706
2024
Q2 		$1.48K Hold
200
– – ﹤0.01% 2492
2024
Q1 		$1.48K Sell
200
-45
-18% -$374 ﹤0.01% 1875
2023
Q4 		$2K Hold
245
– – ﹤0.01% 2132
2023
Q3 		$2K Hold
245
– – ﹤0.01% 1805
2023
Q2 		$2K Hold
245
– – ﹤0.01% 1717
2023
Q1 		$2K Buy
245
+45
+23% +$400 ﹤0.01% 1993
2022
Q4 		$2K Hold
200
– – ﹤0.01% 1914
2022
Q3 		$2K Hold
200
– – ﹤0.01% 1770
2022
Q2 		$4K Buy
+200
New +$2.68K ﹤0.01% 1495

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Blue Trust Inc's EDIT Position: Q2 2026 in Review

Blue Trust Inc sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 1,600 shares — an estimated $3.95K sold.

Blue Trust Inc first reported a position in EDIT in Q2 2022 and held it in 12 quarters. The position peaked at $4K in Q2 2022. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Blue Trust Inc reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
  • Blue Trust Inc sold 1,600 Editas Medicine shares in Q2 2026, an estimated $3.95K.
  • Blue Trust Inc first reported a position in Editas Medicine in Q2 2022 and held it in 12 quarters.
  • Blue Trust Inc's Editas Medicine position peaked at $4K in Q2 2022.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.